Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

25th April in Biotech/pharma of MV History



These articles were published on on 25th April in History. Checkout how time flies, enjoy reading!

Merck's Hepatitis C Treatment Looking Good for Approval

on Apr 25, 2011 1:30 pm by Brett Chase

Merck (MRK) appears to have a good start to a critically important week for its experimental hepatitis C treatment Boceprevir.A Food and Drug Administration staff report prepared for Wednesday's advisory panel meeting found that the drug was effective.Boceprevir is the first of two hepatitis C drugs to be reviewed by a panel of experts who will give their recommendations on whether the drugs... Read More

The Lead-Lag Report: Correction Odds Remain Elevated

on Apr 25, 2012 9:35 am by Michael A. Gayed

MINYANVILLE ORIGINAL You need to overcome the tug of people against you as you reach for high goals. -- George S. Patton Below is an assessment of the performance of some of the most important sectors and asset classes relative to each other, with an interpretation of what underlying market dynamics may be signaling about the future direction of risk-taking by investors. The below ch... Read More

Apples and Oranges: How Safe Is a Market Tied to the Back of One Wild Horse?

on Apr 25, 2012 10:30 am by Jeffrey Cooper

Editor's Note: The following is a free edition of Jeff Cooper's Daily Market Report. For a two-week FREE trial of his daily commentary and nightly day and swing trading picks, click here.MINYANVILLE ORIGINAL Get your cannonball, now to take me down the line My bag is sinking low and I do believe it's time To get back to miss Fanny, you know she's the only one Who sent me here, w... Read More

With Mental Health Emergency Care, Insurers Bank on Hassle Factor

on Apr 25, 2013 10:25 am by Alex Brokaw

We all know that a hospital emergency room can't turn you away if you're in need of care. That's been law since the Emergency Medical Treatment and Active Labor Act was passed in 1986. But, there is a case when an attending doctor might think twice before deciding whether or not you need to be admitted: if you've passed through those sliding doors with a mental health issue, and --... Read More

Conference Call Takeaways: AbbVie Stock Has Little Upside; Ford Set to Outperform Into 2015

on Apr 25, 2014 3:38 pm by Tom Clancy

This article was originally posted on the Buzz & Banter where subscribers can follow over 30 professional traders as they share their ideas in real time. Want access to the Buzz plus unlimited market commentary? Click here to learn more about MVPRO+. Both AbbVie (NYSE:ABBV) and Ford (NYSE:F) had earnings calls today (read the full transcripts here and here). Below are my takeaways from both.... Read More
< Previous
  • 1
Next >
Featured Videos